Express News | Hims & Hers Health Inc: Schultz Joins Board to "Help Company Increase Access to Health and Wellness Solutions"
Express News | Pharmaceutical Industry Chief Kåre Schultz Joins Hims & Hers Board
Express News | Hims & Hers Health Shares Are Trading Lower Following a Report Suggesting That the Company Is Voluntarily Cooperating With a FTC Inquiry
Hims & Hers Says 'Voluntarily Cooperating' With FTC Inquiry
Hims & Hers Says 'Voluntarily Cooperating' With FTC
Truist Securities Adjusts Price Target on Hims & Hers Health to $23 From $13, Maintains Hold Rating
Hims & Hers Health (HIMS) has an average outperform rating and price target range of $13 to $26, according to analysts polled by Capital IQ.Price: 22.00, Change: +0.01, Percent Change: +0.05
Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Announces Target Price $23
Truist Financial analyst Jailendra Singh maintains $Hims & Hers Health(HIMS.US)$ with a hold rating, and sets the target price at $23.According to TipRanks data, the analyst has a success rate of 37.0
Express News | Hims & Hers Health Inc : Truist Securities Raises Target Price to $23 From $13
Press Release: Hims & Hers to Announce Second Quarter 2024 Financial Results on August 5, 2024
Hims & Hers to Announce Second Quarter 2024 Financial Results on August 5, 2024 SAN FRANCISCO--(BUSINESS WIRE)--July 15, 2024-- Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS), the leading
Possible Bearish Signals With Hims & Hers Health Insiders Disposing Stock
Over the past year, many Hims & Hers Health, Inc. (NYSE:HIMS) insiders sold a significant stake in the company which may have piqued investors' interest. Knowing whether insiders are buying is
Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday
U.S. stocks were higher, with the Nasdaq Composite index gaining around 100 points on Friday.Shares of The Bank of New York Mellon Corporation (NYSE:BK) rose during Friday's session following better-
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
Zacks Investment Ideas Feature Highlights: Hims & Hers Health and Ero Copper
Hims & Hers Health Is Maintained at Buy by TD Cowen
Hims & Hers Health Is Maintained at Buy by TD
Hims & Hers Health Price Target Raised to $25.00/Share From $15.00 by TD Cowen
Hims & Hers Health Price Target Raised to $25.00/Share From $15.00 by TD
Piper Sandler Adjusts Price Target on Hims & Hers Health to $18 From $16, Maintains Neutral Rating
Hims & Hers Health (HIMS) has an average outperform rating and price target range of $13 to $26, according to analysts polled by Capital IQ.Price: 21.01, Change: +0.80, Percent Change: +3.96
Hims & Hers Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/11/2024 -11.11% Piper Sandler $16 → $18 Maintains Neutral 06/27/2024 13.58% Jefferies $14 → $23
Piper Sandler Remains a Hold on Hims & Hers Health (HIMS)
TD Cowen Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Raises Target Price to $25
TD Cowen analyst Jonna Kim maintains $Hims & Hers Health(HIMS.US)$ with a buy rating, and adjusts the target price from $15 to $25.According to TipRanks data, the analyst has a success rate of 53.3%
Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS) and Gain Therapeutics (GANX)
Express News | Hims & Hers Health Inc : Piper Sandler Raises Target Price to $18 From $16